🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Shoutout to ⁦Sarah Ahannach⁩ presenting our @isala_project ⁦@BeneMicro⁩ in Amsterdam!

Experiencing the power of networking, literally, at the 10th Beneficial Microbes Conference in Amsterdam. beneficialmicrobes2023.org

The networking session took an interesting spin 🧵😂

One reason may be that lactose inhibits alpha-toxin expression (4-fold) in C.perfringens, which may protect young calves against the toxicity of the toxin/pathogen. It also inhibits the total viable C.perf counts.

The 10th Beneficial Microbes Conference has come to an end. With fond memories of the conference itself, the networking act, and the debate on the (non-)sense of commercial microbiome testing, we're looking forward to the next event in 2025. Stay informed via our social media.

** New Issue ** Beneficial Microbes, Volume 14, No. 5 is out now, with “A probiotic amylase blend reduces gastrointestinal symptoms in a randomised clinical study” by M.B. La Monica et al. in #OpenAccess. brill.ws/BM14-5

The @BeneMicro Conference is over! A big thank you to all the organisers and participants. Our table with S Todorov, one author of "Recommendations for the use of standardised abbreviations for the former Lactobacillus genera, reclassified in the year 2020" soon in #openaccess!

Congratulations to Thibaut Maeyens for winning this year's poster award at the @BeneMicro Conference for "Discovery of novel antimicrobial compounds by investigating the genetic potential of lactic acid bacteria". The reward is an #openaccess publication in Beneficial Microbes 🎉

Beneficial Microbes’ final 2023 issue, Volume 14, No. 6 is out now, with review article “Bifidobacterium adolescentis – a beneficial microbe” by T. Leser and A. Baker in #OpenAccess. brill.ws/BM14-6

This year’s battle was about "The (non-)sense of commercial #microbiome testing". The videorecording is now available at beneficialmicrobes2023.org See you again at the 11th Beneficial Microbes Conference in November 2025. Merry Christmas and a happy new year!

Data Science

How probiotics work compared to drug interventions in IBS? This recent systematic review shows that both probiotic and drug interventions are able to improve the persistence of IBS symptoms: wageningenacademic.com/doi/10.3920/BM…

Beneficial Microbes’ first 2024 issue, Volume 15, No. 1 is out now, with an opinion article, a research article, and a review article in #OpenAccess. See the complete issue here brill.ws/BM15-1

I will be speaking on prebiotics in Salt Lake City for the IPA World Congress + #Probiota Americas 2024 on June, 10 - 12. The 2024 must attend event, will connect the business and science of the microbiome industry! I hope to see you there! bit.ly/Speakers-2024

* New Issue * No less than five #OpenAccess research articles can be found in Beneficial Microbes’ latest issue (Volume 15, No. 2). Out now! brill.ws/BM15-2_

Beneficial Microbes has published a new issue (Vol. 15, No. 4), which opens with #OpenAccess Opinion article “Why do clinical guidelines for probiotics differ?”. The issue also contains five research articles, two of which are in #OpenAccess. brill.ws/BM15-4_

For my Dutch speaking followers: Gezond of gelul? De titel van een BNN/VARA programma. Ik doe mee in aflevering 6; vanaf vandaag online op NPO Start, op 12 Feb uitgezonden op NPO3: npo.nl/start/serie/ge…

In my network: for sale an *Illumina NovaSeq XPlus*. Barely used, served as a back-up. Purchased a year ago for 1.2 MEuro, goes for 660 kEuro. In case of interest, drop me a DM and I'll connect you with the company.

Study in Beneficial Microbes highlighted by NutraIngredients NutraIngredients.com: nutraingredients.com/Article/2025/0…

I’m attending #Probiota Americas 2025 — the leading event for the microbiome, probiotics, prebiotics, and postbiotics industries in North America! 📅 Dates: June 9-11, 2025 📍 Location: Vancouver, Canada Will you be there too? Book your spot: invt.io/1txbgynx0hp